Inventor · disambiguated record
Aaron Smith
Also filed as: SMITH AARON · SMITH AARON C · SMITH AARON CHRISTOPHER
18 granted patents·9 pending applications·63 citations·filing 2003–2025
92Inventor score
Top patents by PatentIndex Score
27 records- 0196US9809579B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2016·Granted Nov 7, 2017·26 cites·26 claims
- 0291US10174007B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2017·Granted Jan 8, 2019·8 cites·12 claims
- 0385US10988463B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2020·Granted Apr 27, 2021·1 cites·8 claims
- 0483US10787438B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2020·Granted Sep 29, 2020·1 cites·24 claims
- 0583US7034033B2Substituted quinazolinone compoundsCHIRON CORP·Filed 2003·Granted Apr 25, 2006·18 cites·44 claims
- 0680US8889730B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Nov 18, 2014·5 cites·5 claims
- 0777US2025084084A1Crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-onePFIZER·Filed 2024·Application pending·0 cites
- 0876US11634410B2Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2021·Granted Apr 25, 2023·0 cites·18 claims
- 0973US12187727B2Methods for antagonizing a melanocortin 4 receptorPFIZER·Filed 2023·Granted Jan 7, 2025·0 cites·20 claims
- 1071US8859773B2N1/N2-lactam acetyl-CoA carboxylase inhibitorsGRIFFITH DAVID A·Filed 2011·Granted Oct 14, 2014·2 cites·3 claims
- 1169US9394285B2Indole and indazole compounds that activate AMPKPFIZER·Filed 2013·Granted Jul 19, 2016·1 cites·6 claims
- 1268US12351581B2Compounds for FGFR inhibitionCOGENT BIOSCIENCES INC·Filed 2024·Granted Jul 8, 2025·0 cites·30 claims
- 1367US12281122B1PI3K inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Granted Apr 22, 2025·0 cites·30 claims
- 1466US11643412B2Melanocortin 4 receptor antagonists and uses thereofPFIZER·Filed 2021·Granted May 9, 2023·0 cites·20 claims
- 1565US2024336572A1Substituted indazole propionic acid derivative compounds and uses thereofPFIZER·Filed 2024·Application pending·0 cites
- 1665US2019106412A1Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitorsPFIZER·Filed 2018·Application pending·0 cites
- 1764US8993586B2N1/N2-lactam acetyl-CoA carboxylase inhibitorsPFIZER·Filed 2014·Granted Mar 31, 2015·0 cites·3 claims
- 1859US7625909B2Substituted quinazolinone compoundsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Dec 1, 2009·1 cites·21 claims
- 1959US2025129048A1Melanocortin 4 receptor antagonists and uses thereofPFIZER·Filed 2022·Application pending·0 cites
- 2058US2025270211A1Compounds for fgfr inhibitionCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2156US2024270741A1Compounds for fgfrs inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2254US9181252B2N1/N2-lactam acetyl-CoA carboxylase inhibitorsPFIZER·Filed 2015·Granted Nov 10, 2015·0 cites·6 claims
- 2354US7858641B2Substituted dihydroisoquinolinone compoundsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Dec 28, 2010·0 cites·9 claims
- 2452US7858631B2Substituted pyrido [2,3-d] pyrimidinone compoundsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Dec 28, 2010·0 cites·6 claims
- 2551US2015038484A1Indole and indazole compounds that activate ampkPFIZER·Filed 2014·Application pending·0 cites
- 2650US2010105654A1Substituted quinazolinone compoundsBOYCE RUSTUM S·Filed 2009·Application pending·0 cites
- 2748US2025206752A1Pi3k inhibitorsCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aaron Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →